Basic Information | Post buying leads | Suppliers |
Name |
Latamoxef sodium |
EINECS | 265-288-4 |
CAS No. | 64953-12-4 | Density | N/A |
PSA | 237.26000 | LogP | -3.46830 |
Solubility | N/A | Melting Point |
N/A |
Formula | C20H18N6Na2O9S | Boiling Point | N/A |
Molecular Weight | 564.48 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | 22-36/37-45 | Risk Codes | 42/43 |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,disodium salt, (6R,7R)- (9CI);6059S;Antibiotic 6059S;Disodium latamoxef;Festamoxin;LY 12735;LY 127935;Latamoxef sodium;Moxalactam disodium;S 6059;Shiomarin;Shionogi 6059S; |
Chemical Name: Latamoxef sodium
IUPAC NAME: Disodium 7-[[2-(4-hydroxyphenyl)-3-oxido-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS No.: 64953-12-4
EINECS: 265-288-4
RTECS: RN6824000
Molecular Formula: C20H18N6Na2O9S
Molecular Weight: 564.44 g/mol
Storage temp.: 2-8°C
Following is the structure of Latamoxef sodium (64953-12-4):
Product Categories about Latamoxef sodium (64953-12-4) are METI - MZForensic and Veterinary Standards;OthersAntibiotics;Penicillins and Cephalosporins (beta-Lactams)More...Close...;Antibacterial;Antibiotics;Antibiotics A to;Antibiotics G-MAntibiotics;Chemical Structure;Chemical Structure Class;Drugs&Metabolites;Interferes with Cell Wall SynthesisSpectrum of Activity;L - ZAlphabetic;M;Mechanism of Action;Neat CompoundsDrugs of Abuse
The chemical synonymous of Latamoxef sodium (64953-12-4) are Moxalactam sodium salt;5-Oxa-1-azabicyclo(4.2.o)oct-2-ene-2-carboxylicacid,7-((carboxy(4-hydroxyphen;6059s;Antibiotic6059-S;Disodiumlatamoxef;Latamoxefsodium;Ly127935;Moxalactamdisodium
1. | orl-man TDLo:571 mg/kg/20D-I:GIT | JAMAAP JAMA, Journal of the American Medical Association. 250 (1983),730. | ||
2. | ivn-man LDLo:371 mg/kg/17D-I:BLD | DICPBB Drug Intelligence and Clinical Pharmacy. 18 (1984),140. | ||
3. | ivn-man TDLo:1143 mg/kg/10D-I:BLD | DICPBB Drug Intelligence and Clinical Pharmacy. 18 (1984),721. | ||
4. | ipr-rat LD50:8100 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. | ||
5. | scu-rat LD50:9000 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. | ||
6. | ivn-rat LD50:5500 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. | ||
7. | ipr-mus LD50:8100 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. | ||
8. | scu-mus LD50:9000 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. | ||
9. | ivn-mus LD50:5500 mg/kg | NIIRDN Drugs in Japan. Ethical Drugs, 6th Edition 1982 6 (1982),APP-21. |
Mildly toxic by several routes. An experimental teratogen. Other experimental reproductive effects. Human systemic effects: ulceration or bleeding from small and large intestine, hemorrhage, thrombocytopenia. When heated to decomposition it emits toxic fumes of SOx, NOx, and Na2O.
Hazard Codes:
Xn: Harmful
Risk Statements about Latamoxef sodium (64953-12-4):
R42/43: May cause sensitization by inhalation and skin contact.
Safety Statements about Latamoxef sodium (64953-12-4):
S22 Do not breathe dust.
S45 In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37: Wear suitable protective clothing and gloves.